As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Medifast's strong quarterly performance, investments in growth strategies, and undervalued stock make it an attractive ...

Medifast’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $17.25 (compared to the current share price of $18.58). When a ...

Charting, Price Performance, News & Related Contracts.

Medifast, Inc. MED is likely to register a decrease ... Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is among the most innovative ...

Medifast assumes no obligation to update any ... it excludes any gains or losses from changes in the market price of our LifeMD common stock holdings, which we are unable to estimate.

DA Davidson analyst Linda Bolton Weiser upgraded Medifast (MED) to Neutral from Underperform with a price target of $17, up from $16.50. With ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Medifast Inc. (MED) on Monday reported profit of $1.1 million in its third quarter. On a per-share basis, the Baltimore-based company said it had profit of 10 cents.